Procalcitonin as a diagnostic aid in diabetic foot infections

Tohoku Journal of Experimental Medicine

Volumn 213, Issue 4, 2007, Pages 305-312

  Uzun, Gunalp ^a   Solmazgul, Emrullah ^a   Curuksulu, Hayrettin ^a   Turhan, Vedat ^a   Ardic, Nurittin ^a   Top, Cihan ^a   Yildiz, Senol ^a   Cimsit, Maide ^b  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

C reactive protein; Erythrocyte sedimentation rate; Infection marker; Procalcitonin; White blood cell count

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC FOOT; DIAGNOSTIC VALUE; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

BACTERIA; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; BLOOD CELL COUNT; C-REACTIVE PROTEIN; CALCITONIN; CASE-CONTROL STUDIES; DIABETIC FOOT; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; ROC CURVE; WOUNDS AND INJURIES;

EID: 38049150984     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.213.305     Document Type: Article

References (23)

1. Balci, C., Sungurtekin, H., Gurses, E., Sungurtekin, U. & Kaptanoglu, B. (2003) Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit. Care, 7, 85-90.
2. Castelli, G.P., Pognani, C., Meisner, M., Stuani, A., Bellomi, D. & Sgarbi, L. (2004) Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit. Care, 8, R234-R242.
3. Christ-Crain, M. & Muller, B. (2005) Procalcitonin in bacterial infections-hype, hope, more or less? Swiss Med. Wkly., 135, 451-460.
4. Eneroth, M., Larsson, J. & Apelqvist, J. (1999) Deep foot infections in patients with diabetes and foot ulcer: an entity with different characteristics, treatments, and prognosis. J. Diabetes Complications, 13, 254-263.
5. Giamarellou, H., Giamarellos-Bourboulis, E.J., Repoussis, P., Galani, L., Anagnostopoulos, N., Grecka, P., Lubos, D., Aoun, M., Athanassiou, K., Bouza, E., Devigili, E., Krcmery, V., Menichetti, F., Panaretou, E., Papageorgiou, E. & Plachouras, D. (2004) Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Clin. Microbiol. Infect., 10, 628-633.
6. Grayson, M.L., Gibbons, G.W., Balogh, G., Levin, E. & Karchmer, A.W. (1995) Probing to bone in infected pedal ulcers. JAMA, 273, 721-723.
7. Hatherill, M., Tibby, S.M., Sykes, K., Turner, C. & Murdoch, I.A. (1999) Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count. Arch. Dis. Child, 81, 417-421.
8. Kaleta, J.L., Fleischli, J.W., & Reilly, C.H. (2001) The diagnosis of osteomyelitis in diabetes using erythrocyte sedimentation rate: a pilot study. J. Am. Podiatr. Med. Assoc., 91, 445-450.
9. King, D.E., Mainous, A.G., III., Buchanan, T.A. & Pearson, W.S. (2003) C-reactive protein and glycemic control in adults with diabetes. Diabetes Care, 26, 1535-1539.
10. Lipsky, B.A., Berendt, A.R., Deery, H.G., Embil, J.M., Joseph, W.S., Karchmer, A.W., LeFrock, J.L., Lew, D.P., Mader, J.T., Norden, C. & Tan, J.S. (2004) Diagnosis and treatment of diabetic foot infections. Clin. Infect. Dis., 39, 885-910.
11. Luzzani, A., Polati, E., Dorizzi, R., Rungatscher, A., Pavan, R. & Merlini, A. (2003) Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit. Care Med., 31, 1737-1741.
12. Mayfield, J.A., Reiber, G.E., Maynard, C., Czerniecki, J. & Sangeorzan, B. (2004) The epidemiology of lower-extremity disease in veterans with diabetes. Diabetes Care, 27, B39-B44.
13. Moulin, F., Raymond, J., Lorrot, M., Marc, E., Coste, J., Iniguez, J.L., Kalifa, G., Bohuon, C. & Gendrel, D. (2001) Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch. Dis. Child., 84, 332-336.
14. Muller, B. & Becker, K.L. (2001) Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med. Wkly., 131, 595-602.
15. Oyibo, S.O., Jude, E.B., Tarawneh, I., Nguyen, H.C., Armstrong, D.G., Harkless, L.B. & Boulton, A.J. (2001) The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet. Med., 18, 133-138.
16. Pecoraro, R.E., Reiber, G.E. & Burgess, E.M. (1990) Pathways to diabetic limb amputation: basis for prevention. Diabetes Care, 13, 513-521.
17. Ramsey, S.D., Newton, K., Blough, D., McCulloch, D.K., Sandhu, N., Reiber, G.E. & Wagner, E.H. (1999) Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care, 22, 382-387.
18. Reiber, G.E., Boyko, E.J. & Smith, D.G. (1995) Lower extremity foot ulcers and amputations in diabetes. In: Diabetes in America, 2nd ed., National Diabetes Data Group, National Institutes of Health Publication No. 95-1468, Bethesda, MD, pp. 409-428
19. Singh, N., Armstrong, D.G. & Lipsky, B.A. (2005) Preventing foot ulcers in patients with diabetes. JAMA, 293, 217-228.
20. Snider, R.H., Jr., Nylen, E.S. & Becker, K.L. (1997) Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J. Investig. Med., 45, 552-560.
21. Upchurch, G.R., Jr., Keagy, B.A. & Johnson, G., Jr. (1997) An acute phase reaction in diabetic patients with foot ulcers. Cardiovasc. Surg., 5, 32-36.
22. Wagner, W.F., Jr. (1981) The disvasculat foot: a system for diagnosis and treatment. Foot Ankle, 2, 64-122.
23. Williams, D.T., Hilton, J.R. & Harding, K.G. (2004) Diagnosing foot infection in diabetes. Clin. Infect. Dis., 39 (Suppl. 2), S83-S86.